ORIC Pharmaceuticals, Inc. (ORIC)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jacob M. Chacko
Employees:
80
240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA 94080
(650) 388-5600

ORIC Pharmaceuticals, Inc. discovers and develops therapies for treatment of cancers. Its product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Data derived from most recent annual or quarterly report
Market Cap 126.33 Million Shares Outstanding39.478 Million Avg 30-day Volume 143.018 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.02
Price to Revenue0.0 Debt to Equity0.0 EBITDA-83.844 Million
Price to Book Value0.7467 Operating Margin0.0 Enterprise Value-60.958 Million
Current Ratio18.721 EPS Growth-4.644 Quick Ratio18.203
1 Yr BETA 0.9685 52-week High/Low 21.18 / 2.62 Profit Margin0.0
Operating Cash Flow Growth-17.7717 Altman Z-Score3.0348 Free Cash Flow to Firm -61.43 Million
Earnings Report2022-11-08
View SEC Filings from ORIC instead.

View recent insider trading info

Funds Holding ORIC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ORIC

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-21:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MULTANI PRATIK S CHIEF MEDICAL OFFICER

    • Officer
    346,250 2022-07-20 2

    CHACKO JACOB PRESIDENT AND CEO

    • Officer
    • Director
    1,017,500 2022-07-20 4

    PISCITELLI DOMINIC CHIEF FINANCIAL OFFICER

    • Officer
    492,500 2022-07-20 3

    HOERTER STEVEN L.

    • Director
    50,283 2022-06-17 1

    KUNKEL LORI ANNE

    • Director
    53,700 2022-06-17 1

    DIER MARDI

    • Director
    53,700 2022-06-17 1

    HEYMAN RICHARD A.

    • Director
    53,700 2022-06-17 1

    YOU ANGIE

    • Director
    45,158 2022-06-17 3

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    GOEDDEL DAVID V

    SVENNILSON PETER

    COLUMN GROUP LLC

    • 10% Owner
    3,758,312 2021-11-12 1

    GORDON CARL L

    • Director
    • 10% Owner
    16,625 2021-06-16 0

    SVENNILSON PETER

    • Director
    • 10% Owner
    16,625 2021-06-16 0

    SCHELLER RICHARD H

    • Director
    39,092 2021-05-20 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    • Director
    2,212,571 2021-03-29 0

    TOPSPIN FUND L.P.

    TOPSPIN BIOTECH FUND II, L.P.

    LG MANAGEMENT, LLC

    GUTHART LEO

    • 10% Owner
    No longer subject to file 2020-11-04 0

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    GOEDDEL DAVID V

    • 10% Owner
    • GENERAL PARTNERMANAGING PARTNER
    4,768,181 2020-04-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 22:15:04 UTC 1.1103 1.9597 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 21:45:03 UTC 1.1103 1.9597 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 21:15:03 UTC 1.1103 1.9597 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 20:45:04 UTC 1.1103 1.9597 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 20:15:03 UTC 1.1103 1.9597 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 19:45:03 UTC 1.1103 1.9597 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 19:15:03 UTC 1.1103 1.9597 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 18:45:03 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 18:15:04 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 17:45:04 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 17:15:03 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 16:45:04 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 16:15:03 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 15:45:03 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 15:15:03 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 14:45:03 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 14:15:03 UTC 1.3564 1.7136 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 13:45:03 UTC 1.0268 2.0432 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 13:15:03 UTC 1.0268 2.0432 800000
    ORIC PHARMACEUTICALS INC ORIC 2022-09-30 12:45:03 UTC 1.0268 2.0432 800000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund ORIC -1100.0 shares, $-19459.0 2021-06-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments